Taho Pharmaceuticals Ltd. (TPEX:6467)
Taiwan · Delayed Price · Currency is TWD 124.50
+1.00 (0.81%)
At close: Feb 11, 2026
Taho Pharmaceuticals Market Cap
Taho Pharmaceuticals has a market cap or net worth of 6.4 billion as of February 13, 2026. Its market cap has increased by 152.89% in one year.
Market Cap
6.40B
Enterprise Value
6.01B
Revenue
7.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
124.50
Market Cap Chart
Since August 14, 2014, Taho Pharmaceuticals's market cap has increased from 2.09B to 6.40B, an increase of 206.13%. That is a compound annual growth rate of 10.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 6.40B | 11.66% |
| Dec 31, 2025 | 5.73B | 151.98% |
| Dec 31, 2024 | 2.27B | 1,107.48% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Liying Environmental Protection Technology | 6.49B |
| Orient Pharma | 6.49B |
| Avalue Technology Incorporation | 6.49B |
| Macnica Galaxy | 6.45B |
| Franbo Lines | 6.43B |
| Sinmag Equipment | 6.39B |
| Phoenix Pioneer technology | 6.34B |
| ChenFull Precision | 6.30B |